4) 174,175 and this pool increases with age
Menter A, Gelfand JM, Connor C, Armstrong AW, Cordoro KM, Davis DMR, Elewski BE, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kivelevitch D, Korman NJ, Kroshinsky D, Lebwohl M, Leonardi CL, Lichten J, Lim H, W.,Elmets, C
They're the long-established standard of care, both FDA-approved, both backed by decades of clinical data

Brain AT 1 -R has been reported to play a role in blood pressure and fluid homeostasis regulation, stress responses, depression and cognition, among others ( 1 -R density, where they positively modulate dopamine synthesis, tonic, and evoked release ( 1 -R modulate DA hyperreactivity induced by a single exposure of AMPH in caudate-putamen and nucleus accumbens ( 1 -R blockade prevented the AMPH-induced locomotor sensitization and reversed the psychostimulant-induced locomotor sensitization when these receptors where locally antagonized in the caudate-putamen ( Moreover, the presence of AT 1 -R has been described in all the components of the neurovascular unit ( 1 -R are constitutively expressed in astrocytes and their activation induces increased intracellular Ca 2+ with the subsequent induction of early gene transcription ( 1 -R is associated with imbalance in vascular tone regulators together with vascular leakage and inflammatory cell recruitment ( AT 1 -R blockers are currently used in the antihypertensive treatment and have a low incidence of adverse effects, even in elderly patients and they do not alter blood pressure in normotensive patients ( 1 -R blockers available, candesartan (CAND) shows the tightest and longest-lasting binding to AT 1 -R ( 1 -R activation/stimulation has overlapping effects with AMPH in the neurovascular unit components, make AT 1 -R blockers a potential pharmacological tool to modulate some deleterious effects induced by AMPH
